Results 141 to 150 of about 43,933 (287)

Toronto's drug policy paradox: Harm reduction sites and drug police occurrences in Toronto neighborhoods (1992–2020)

Criminology, EarlyView.
Abstract Discourse around drug policy presents a stark contrast between policing and harm reduction models, sparking debates on the state's regulatory versus protective role. Canada is an ideal case to study drug policy models due to its global recognition as a leader in harm reduction alongside continued reliance on policing of drugs.
Taylor Domingos
wiley   +1 more source

Efficacy and Safety of Medical Marijuana in Migraine Headache: A Systematic Review. [PDF]

Cureus, 2022
Sherpa ML, Shrestha N, Ojinna BT, Ravi N, Shantha Kumar V, Choday S, Parisapogu A, Tran HH, Kc A, Elshaikh AO.   +9 more
europepmc   +1 more source

Medical marijuana informational bulletin (2024)

This archived document is maintained by the Oregon State Library as part of the Oregon Documents Depository Program. It is for informational purposes and may not be suitable for legal purposesCovers OCLC #972679813, OCLC #1416920395, OCLC #1416920457 ...

core  

Diagnostic validation of the 00325 Inadequate Self‐Compassion

International Journal of Nursing Knowledge, EarlyView.
Abstract Background Self‐compassion is an essential component of self‐care. Recognizing it as a nursing diagnosis can promote interventions to address Inadequate Self‐Compassion. Aim This study aims to clinically validate the new NANDA‐I diagnosis (00325) Inadequate Self‐Compassion.
Aarón Muñoz‐Devesa, Daniel Guillén‐Martínez, Adriana Caterina de Souza‐Oliveira, Daniel Muñoz‐Jimenez, Paloma Echevarría‐Pérez, Isabel Morales‐Moreno   +5 more
wiley   +1 more source

Experience With Medical Marijuana for Cancer Patients in the Palliative Setting. [PDF]

Cureus, 2022
Sura KT, Kohman L, Huang D, Pasniciuc SV.   +3 more
europepmc   +1 more source

Medical marijuana.

The Western journal of medicine, 1998
Although many clinical studies suggest the medical utility of marijuana for some conditions, the scientific evidence is weak. Many patients in California are self-medicating with marijuana, and physicians need data to assess the risks and benefits. The only reasonable solution to this problem is to encourage research on the medical effects of marijuana.
openaire   +3 more sources

Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Research indicates that first‐episode psychosis (FEP) with cannabis use disorder (CUD) carries a substantial disease burden, but more granular clinical trajectories of cannabis‐related psychoses remain unclear. This study examines the clinical trajectories of first clinically diagnosed FEP&CUD and cannabis‐induced psychosis (CIP) in
Antti Mustonen, Solja Niemelä, Alexander Denissoff, Antti Tanskanen, Ellenor Mittendorfer‐Rutz, Markku Lähteenvuo, Jari Tiihonen, Heidi Taipale   +7 more
wiley   +1 more source

The Construct of Medical and Non-Medical Marijuana-Critical Review. [PDF]

Int J Environ Res Public Health, 2022
Silczuk A, Smułek D, Kołodziej M, Gujska J.   +3 more
europepmc   +1 more source

Electroconvulsive Therapy and Time to Psychiatric Readmission in Schizophrenia

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction There is evidence that electroconvulsive therapy (ECT) can augment the effects of antipsychotics in schizophrenia. However, there is limited evidence from Western populations on whether ECT reduces the risk of relapse compared to non‐ECT treatment in schizophrenia.
Linnea Stenmark, Mussie Msghina, Axel Nordenskjöld   +2 more
wiley   +1 more source

Observational study of medical marijuana as a treatment for treatment-resistant epilepsies. [PDF]

Ann Clin Transl Neurol, 2022
Devinsky O, Marmanillo A, Hamlin T, Wilken P, Ryan D, Anderson C, Friedman D, Todd G.   +7 more
europepmc   +1 more source